{"entity":{"type":"insider","cik":"0001695580","url":"/insider/0001695580","json_url":"/insider/0001695580.json","name":"Krogulski Kenneth","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":593,"n_filings":30,"first":"2017-03-24","last":"2025-09-12","span_basis":"filed_date"},"name_variants":[{"name":"Krogulski Kenneth","source":"filing","n_filings":30,"first_seen":"2017-03-24","last_seen":"2025-09-12"}],"transactions":[{"id":5055706,"accession":"0001628280-25-041983","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001628280-25-041983","line_url":"/filing/0001628280-25-041983#line-21","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":68.0,"shares_display":"68","price_per_share":3.45,"price_display":"3.45","price_state":"stated","total_value":234.6,"total_display":"234.60","total_whole":"235","shares_owned_after":289717.0,"shares_owned_after_display":"289,717","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-29","filed_date":"2025-09-12","scope":"insider"},{"id":5055704,"accession":"0001628280-25-041983","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001628280-25-041983","line_url":"/filing/0001628280-25-041983#line-20","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":68.0,"shares_display":"68","price_per_share":3.47,"price_display":"3.47","price_state":"stated","total_value":235.96,"total_display":"235.96","total_whole":"236","shares_owned_after":289649.0,"shares_owned_after_display":"289,649","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-28","filed_date":"2025-09-12","scope":"insider"},{"id":5055699,"accession":"0001628280-25-041983","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001628280-25-041983","line_url":"/filing/0001628280-25-041983#line-19","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":68.0,"shares_display":"68","price_per_share":3.44,"price_display":"3.44","price_state":"stated","total_value":233.92,"total_display":"233.92","total_whole":"234","shares_owned_after":289581.0,"shares_owned_after_display":"289,581","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-27","filed_date":"2025-09-12","scope":"insider"},{"id":5055695,"accession":"0001628280-25-041983","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001628280-25-041983","line_url":"/filing/0001628280-25-041983#line-18","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":68.0,"shares_display":"68","price_per_share":3.39,"price_display":"3.39","price_state":"stated","total_value":230.52,"total_display":"230.52","total_whole":"231","shares_owned_after":289513.0,"shares_owned_after_display":"289,513","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-26","filed_date":"2025-09-12","scope":"insider"},{"id":5055690,"accession":"0001628280-25-041983","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001628280-25-041983","line_url":"/filing/0001628280-25-041983#line-17","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":68.0,"shares_display":"68","price_per_share":3.32,"price_display":"3.32","price_state":"stated","total_value":225.76,"total_display":"225.76","total_whole":"226","shares_owned_after":289445.0,"shares_owned_after_display":"289,445","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-25","filed_date":"2025-09-12","scope":"insider"},{"id":5055685,"accession":"0001628280-25-041983","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001628280-25-041983","line_url":"/filing/0001628280-25-041983#line-16","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":68.0,"shares_display":"68","price_per_share":3.32,"price_display":"3.32","price_state":"stated","total_value":225.76,"total_display":"225.76","total_whole":"226","shares_owned_after":289377.0,"shares_owned_after_display":"289,377","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-22","filed_date":"2025-09-12","scope":"insider"},{"id":5055681,"accession":"0001628280-25-041983","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001628280-25-041983","line_url":"/filing/0001628280-25-041983#line-15","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":68.0,"shares_display":"68","price_per_share":3.31,"price_display":"3.31","price_state":"stated","total_value":225.08,"total_display":"225.08","total_whole":"225","shares_owned_after":289309.0,"shares_owned_after_display":"289,309","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-21","filed_date":"2025-09-12","scope":"insider"},{"id":5055678,"accession":"0001628280-25-041983","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001628280-25-041983","line_url":"/filing/0001628280-25-041983#line-14","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12.0,"shares_display":"12","price_per_share":3.15,"price_display":"3.15","price_state":"stated","total_value":37.8,"total_display":"37.80","total_whole":"38","shares_owned_after":289241.0,"shares_owned_after_display":"289,241","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-20","filed_date":"2025-09-12","scope":"insider"},{"id":5055674,"accession":"0001628280-25-041983","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001628280-25-041983","line_url":"/filing/0001628280-25-041983#line-13","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":68.0,"shares_display":"68","price_per_share":3.23,"price_display":"3.23","price_state":"stated","total_value":219.64,"total_display":"219.64","total_whole":"220","shares_owned_after":289229.0,"shares_owned_after_display":"289,229","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-19","filed_date":"2025-09-12","scope":"insider"},{"id":5055668,"accession":"0001628280-25-041983","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001628280-25-041983","line_url":"/filing/0001628280-25-041983#line-12","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":68.0,"shares_display":"68","price_per_share":3.11,"price_display":"3.11","price_state":"stated","total_value":211.48,"total_display":"211.48","total_whole":"211","shares_owned_after":289161.0,"shares_owned_after_display":"289,161","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-18","filed_date":"2025-09-12","scope":"insider"},{"id":5055663,"accession":"0001628280-25-041983","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001628280-25-041983","line_url":"/filing/0001628280-25-041983#line-11","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":68.0,"shares_display":"68","price_per_share":3.02,"price_display":"3.02","price_state":"stated","total_value":205.36,"total_display":"205.36","total_whole":"205","shares_owned_after":289093.0,"shares_owned_after_display":"289,093","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-15","filed_date":"2025-09-12","scope":"insider"},{"id":5055656,"accession":"0001628280-25-041983","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001628280-25-041983","line_url":"/filing/0001628280-25-041983#line-10","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":68.0,"shares_display":"68","price_per_share":2.84,"price_display":"2.84","price_state":"stated","total_value":193.12,"total_display":"193.12","total_whole":"193","shares_owned_after":289025.0,"shares_owned_after_display":"289,025","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-14","filed_date":"2025-09-12","scope":"insider"},{"id":5055653,"accession":"0001628280-25-041983","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001628280-25-041983","line_url":"/filing/0001628280-25-041983#line-9","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":68.0,"shares_display":"68","price_per_share":2.94,"price_display":"2.94","price_state":"stated","total_value":199.92,"total_display":"199.92","total_whole":"200","shares_owned_after":288957.0,"shares_owned_after_display":"288,957","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-13","filed_date":"2025-09-12","scope":"insider"},{"id":5055647,"accession":"0001628280-25-041983","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001628280-25-041983","line_url":"/filing/0001628280-25-041983#line-8","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":68.0,"shares_display":"68","price_per_share":2.91,"price_display":"2.91","price_state":"stated","total_value":197.88,"total_display":"197.88","total_whole":"198","shares_owned_after":288889.0,"shares_owned_after_display":"288,889","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-12","filed_date":"2025-09-12","scope":"insider"},{"id":5055638,"accession":"0001628280-25-041983","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001628280-25-041983","line_url":"/filing/0001628280-25-041983#line-7","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":68.0,"shares_display":"68","price_per_share":2.87,"price_display":"2.87","price_state":"stated","total_value":195.16,"total_display":"195.16","total_whole":"195","shares_owned_after":288821.0,"shares_owned_after_display":"288,821","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-11","filed_date":"2025-09-12","scope":"insider"},{"id":5055635,"accession":"0001628280-25-041983","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001628280-25-041983","line_url":"/filing/0001628280-25-041983#line-6","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":68.0,"shares_display":"68","price_per_share":3.39,"price_display":"3.39","price_state":"stated","total_value":230.52,"total_display":"230.52","total_whole":"231","shares_owned_after":288753.0,"shares_owned_after_display":"288,753","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-08","filed_date":"2025-09-12","scope":"insider"},{"id":5055631,"accession":"0001628280-25-041983","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001628280-25-041983","line_url":"/filing/0001628280-25-041983#line-5","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":68.0,"shares_display":"68","price_per_share":3.14,"price_display":"3.14","price_state":"stated","total_value":213.52,"total_display":"213.52","total_whole":"214","shares_owned_after":288685.0,"shares_owned_after_display":"288,685","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-07","filed_date":"2025-09-12","scope":"insider"},{"id":5055627,"accession":"0001628280-25-041983","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001628280-25-041983","line_url":"/filing/0001628280-25-041983#line-4","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":68.0,"shares_display":"68","price_per_share":3.34,"price_display":"3.34","price_state":"stated","total_value":227.12,"total_display":"227.12","total_whole":"227","shares_owned_after":288617.0,"shares_owned_after_display":"288,617","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-06","filed_date":"2025-09-12","scope":"insider"},{"id":5055624,"accession":"0001628280-25-041983","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-25-041983","line_url":"/filing/0001628280-25-041983#line-3","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":68.0,"shares_display":"68","price_per_share":3.92,"price_display":"3.92","price_state":"stated","total_value":266.56,"total_display":"266.56","total_whole":"267","shares_owned_after":288549.0,"shares_owned_after_display":"288,549","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-05","filed_date":"2025-09-12","scope":"insider"},{"id":5055622,"accession":"0001628280-25-041983","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-25-041983","line_url":"/filing/0001628280-25-041983#line-2","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":68.0,"shares_display":"68","price_per_share":4.01,"price_display":"4.01","price_state":"stated","total_value":272.68,"total_display":"272.68","total_whole":"273","shares_owned_after":288481.0,"shares_owned_after_display":"288,481","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-04","filed_date":"2025-09-12","scope":"insider"},{"id":5055617,"accession":"0001628280-25-041983","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-041983","line_url":"/filing/0001628280-25-041983#line-1","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":68.0,"shares_display":"68","price_per_share":3.44,"price_display":"3.44","price_state":"stated","total_value":233.92,"total_display":"233.92","total_whole":"234","shares_owned_after":288413.0,"shares_owned_after_display":"288,413","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-01","filed_date":"2025-09-12","scope":"insider"},{"id":4929525,"accession":"0001628280-25-039397","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001628280-25-039397","line_url":"/filing/0001628280-25-039397#line-22","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":68.0,"shares_display":"68","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":238.0,"total_display":"238.00","total_whole":"238","shares_owned_after":288345.0,"shares_owned_after_display":"288,345","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-31","filed_date":"2025-08-11","scope":"insider"},{"id":4929522,"accession":"0001628280-25-039397","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001628280-25-039397","line_url":"/filing/0001628280-25-039397#line-21","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":68.0,"shares_display":"68","price_per_share":3.55,"price_display":"3.55","price_state":"stated","total_value":241.4,"total_display":"241.40","total_whole":"241","shares_owned_after":288277.0,"shares_owned_after_display":"288,277","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-30","filed_date":"2025-08-11","scope":"insider"},{"id":4929519,"accession":"0001628280-25-039397","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001628280-25-039397","line_url":"/filing/0001628280-25-039397#line-20","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":68.0,"shares_display":"68","price_per_share":3.33,"price_display":"3.33","price_state":"stated","total_value":226.44,"total_display":"226.44","total_whole":"226","shares_owned_after":288209.0,"shares_owned_after_display":"288,209","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-29","filed_date":"2025-08-11","scope":"insider"},{"id":4929516,"accession":"0001628280-25-039397","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001628280-25-039397","line_url":"/filing/0001628280-25-039397#line-19","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":68.0,"shares_display":"68","price_per_share":3.47,"price_display":"3.47","price_state":"stated","total_value":235.96,"total_display":"235.96","total_whole":"236","shares_owned_after":288141.0,"shares_owned_after_display":"288,141","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-28","filed_date":"2025-08-11","scope":"insider"},{"id":4929514,"accession":"0001628280-25-039397","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001628280-25-039397","line_url":"/filing/0001628280-25-039397#line-18","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":80.0,"shares_display":"80","price_per_share":3.37,"price_display":"3.37","price_state":"stated","total_value":269.6,"total_display":"269.60","total_whole":"270","shares_owned_after":288073.0,"shares_owned_after_display":"288,073","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-25","filed_date":"2025-08-11","scope":"insider"},{"id":4929510,"accession":"0001628280-25-039397","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001628280-25-039397","line_url":"/filing/0001628280-25-039397#line-17","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":80.0,"shares_display":"80","price_per_share":3.55,"price_display":"3.55","price_state":"stated","total_value":284.0,"total_display":"284.00","total_whole":"284","shares_owned_after":287993.0,"shares_owned_after_display":"287,993","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-24","filed_date":"2025-08-11","scope":"insider"},{"id":4929507,"accession":"0001628280-25-039397","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001628280-25-039397","line_url":"/filing/0001628280-25-039397#line-16","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":80.0,"shares_display":"80","price_per_share":3.54,"price_display":"3.54","price_state":"stated","total_value":283.2,"total_display":"283.20","total_whole":"283","shares_owned_after":287913.0,"shares_owned_after_display":"287,913","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-23","filed_date":"2025-08-11","scope":"insider"},{"id":4929503,"accession":"0001628280-25-039397","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001628280-25-039397","line_url":"/filing/0001628280-25-039397#line-15","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":80.0,"shares_display":"80","price_per_share":3.47,"price_display":"3.47","price_state":"stated","total_value":277.6,"total_display":"277.60","total_whole":"278","shares_owned_after":287833.0,"shares_owned_after_display":"287,833","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-22","filed_date":"2025-08-11","scope":"insider"},{"id":4929496,"accession":"0001628280-25-039397","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001628280-25-039397","line_url":"/filing/0001628280-25-039397#line-14","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":80.0,"shares_display":"80","price_per_share":3.45,"price_display":"3.45","price_state":"stated","total_value":276.0,"total_display":"276.00","total_whole":"276","shares_owned_after":287753.0,"shares_owned_after_display":"287,753","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-21","filed_date":"2025-08-11","scope":"insider"},{"id":4929492,"accession":"0001628280-25-039397","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001628280-25-039397","line_url":"/filing/0001628280-25-039397#line-13","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":80.0,"shares_display":"80","price_per_share":3.59,"price_display":"3.59","price_state":"stated","total_value":287.2,"total_display":"287.20","total_whole":"287","shares_owned_after":287673.0,"shares_owned_after_display":"287,673","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-18","filed_date":"2025-08-11","scope":"insider"},{"id":4929489,"accession":"0001628280-25-039397","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001628280-25-039397","line_url":"/filing/0001628280-25-039397#line-12","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":80.0,"shares_display":"80","price_per_share":3.82,"price_display":"3.82","price_state":"stated","total_value":305.6,"total_display":"305.60","total_whole":"306","shares_owned_after":287593.0,"shares_owned_after_display":"287,593","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-17","filed_date":"2025-08-11","scope":"insider"},{"id":4929486,"accession":"0001628280-25-039397","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001628280-25-039397","line_url":"/filing/0001628280-25-039397#line-11","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":80.0,"shares_display":"80","price_per_share":3.79,"price_display":"3.79","price_state":"stated","total_value":303.2,"total_display":"303.20","total_whole":"303","shares_owned_after":287513.0,"shares_owned_after_display":"287,513","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-16","filed_date":"2025-08-11","scope":"insider"},{"id":4929483,"accession":"0001628280-25-039397","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001628280-25-039397","line_url":"/filing/0001628280-25-039397#line-10","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":80.0,"shares_display":"80","price_per_share":3.45,"price_display":"3.45","price_state":"stated","total_value":276.0,"total_display":"276.00","total_whole":"276","shares_owned_after":287433.0,"shares_owned_after_display":"287,433","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-15","filed_date":"2025-08-11","scope":"insider"},{"id":4929480,"accession":"0001628280-25-039397","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001628280-25-039397","line_url":"/filing/0001628280-25-039397#line-9","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":80.0,"shares_display":"80","price_per_share":3.46,"price_display":"3.46","price_state":"stated","total_value":276.8,"total_display":"276.80","total_whole":"277","shares_owned_after":287353.0,"shares_owned_after_display":"287,353","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-14","filed_date":"2025-08-11","scope":"insider"},{"id":4929469,"accession":"0001628280-25-039397","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001628280-25-039397","line_url":"/filing/0001628280-25-039397#line-8","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":80.0,"shares_display":"80","price_per_share":3.21,"price_display":"3.21","price_state":"stated","total_value":256.8,"total_display":"256.80","total_whole":"257","shares_owned_after":287273.0,"shares_owned_after_display":"287,273","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-11","filed_date":"2025-08-11","scope":"insider"},{"id":4929464,"accession":"0001628280-25-039397","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001628280-25-039397","line_url":"/filing/0001628280-25-039397#line-7","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":80.0,"shares_display":"80","price_per_share":3.2,"price_display":"3.20","price_state":"stated","total_value":256.0,"total_display":"256.00","total_whole":"256","shares_owned_after":287193.0,"shares_owned_after_display":"287,193","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-10","filed_date":"2025-08-11","scope":"insider"},{"id":4929458,"accession":"0001628280-25-039397","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001628280-25-039397","line_url":"/filing/0001628280-25-039397#line-6","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":80.0,"shares_display":"80","price_per_share":3.05,"price_display":"3.05","price_state":"stated","total_value":244.0,"total_display":"244.00","total_whole":"244","shares_owned_after":287113.0,"shares_owned_after_display":"287,113","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-09","filed_date":"2025-08-11","scope":"insider"},{"id":4929452,"accession":"0001628280-25-039397","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001628280-25-039397","line_url":"/filing/0001628280-25-039397#line-5","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":80.0,"shares_display":"80","price_per_share":3.06,"price_display":"3.06","price_state":"stated","total_value":244.8,"total_display":"244.80","total_whole":"245","shares_owned_after":287033.0,"shares_owned_after_display":"287,033","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-08","filed_date":"2025-08-11","scope":"insider"},{"id":4929444,"accession":"0001628280-25-039397","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001628280-25-039397","line_url":"/filing/0001628280-25-039397#line-4","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":80.0,"shares_display":"80","price_per_share":3.23,"price_display":"3.23","price_state":"stated","total_value":258.4,"total_display":"258.40","total_whole":"258","shares_owned_after":286953.0,"shares_owned_after_display":"286,953","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-07","filed_date":"2025-08-11","scope":"insider"},{"id":4929440,"accession":"0001628280-25-039397","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-25-039397","line_url":"/filing/0001628280-25-039397#line-3","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":80.0,"shares_display":"80","price_per_share":3.31,"price_display":"3.31","price_state":"stated","total_value":264.8,"total_display":"264.80","total_whole":"265","shares_owned_after":286873.0,"shares_owned_after_display":"286,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-03","filed_date":"2025-08-11","scope":"insider"},{"id":4929437,"accession":"0001628280-25-039397","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-25-039397","line_url":"/filing/0001628280-25-039397#line-2","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":80.0,"shares_display":"80","price_per_share":3.52,"price_display":"3.52","price_state":"stated","total_value":281.6,"total_display":"281.60","total_whole":"282","shares_owned_after":286793.0,"shares_owned_after_display":"286,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-02","filed_date":"2025-08-11","scope":"insider"},{"id":4929430,"accession":"0001628280-25-039397","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-039397","line_url":"/filing/0001628280-25-039397#line-1","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":80.0,"shares_display":"80","price_per_share":3.56,"price_display":"3.56","price_state":"stated","total_value":284.8,"total_display":"284.80","total_whole":"285","shares_owned_after":286713.0,"shares_owned_after_display":"286,713","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-01","filed_date":"2025-08-11","scope":"insider"},{"id":4536353,"accession":"0001628280-25-034814","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001628280-25-034814","line_url":"/filing/0001628280-25-034814#line-20","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":80.0,"shares_display":"80","price_per_share":2.74,"price_display":"2.74","price_state":"stated","total_value":219.2,"total_display":"219.20","total_whole":"219","shares_owned_after":286633.0,"shares_owned_after_display":"286,633","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-30","filed_date":"2025-07-11","scope":"insider"},{"id":4536351,"accession":"0001628280-25-034814","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001628280-25-034814","line_url":"/filing/0001628280-25-034814#line-19","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":45.0,"shares_display":"45","price_per_share":2.6,"price_display":"2.60","price_state":"stated","total_value":117.0,"total_display":"117.00","total_whole":"117","shares_owned_after":286553.0,"shares_owned_after_display":"286,553","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-27","filed_date":"2025-07-11","scope":"insider"},{"id":4536347,"accession":"0001628280-25-034814","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001628280-25-034814","line_url":"/filing/0001628280-25-034814#line-18","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":45.0,"shares_display":"45","price_per_share":2.71,"price_display":"2.71","price_state":"stated","total_value":121.95,"total_display":"121.95","total_whole":"122","shares_owned_after":286508.0,"shares_owned_after_display":"286,508","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-26","filed_date":"2025-07-11","scope":"insider"},{"id":4536344,"accession":"0001628280-25-034814","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001628280-25-034814","line_url":"/filing/0001628280-25-034814#line-17","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":45.0,"shares_display":"45","price_per_share":3.27,"price_display":"3.27","price_state":"stated","total_value":147.15,"total_display":"147.15","total_whole":"147","shares_owned_after":286463.0,"shares_owned_after_display":"286,463","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-25","filed_date":"2025-07-11","scope":"insider"},{"id":4536340,"accession":"0001628280-25-034814","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001628280-25-034814","line_url":"/filing/0001628280-25-034814#line-16","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":45.0,"shares_display":"45","price_per_share":3.91,"price_display":"3.91","price_state":"stated","total_value":175.95,"total_display":"175.95","total_whole":"176","shares_owned_after":286418.0,"shares_owned_after_display":"286,418","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-24","filed_date":"2025-07-11","scope":"insider"},{"id":4536337,"accession":"0001628280-25-034814","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001628280-25-034814","line_url":"/filing/0001628280-25-034814#line-15","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":45.0,"shares_display":"45","price_per_share":4.61,"price_display":"4.61","price_state":"stated","total_value":207.45,"total_display":"207.45","total_whole":"207","shares_owned_after":286373.0,"shares_owned_after_display":"286,373","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-23","filed_date":"2025-07-11","scope":"insider"},{"id":4536335,"accession":"0001628280-25-034814","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001628280-25-034814","line_url":"/filing/0001628280-25-034814#line-14","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001695580","owner_name":"Krogulski Kenneth","owner_display_name":"Krogulski Kenneth","owner_url":"/insider/0001695580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":45.0,"shares_display":"45","price_per_share":5.29,"price_display":"5.29","price_state":"stated","total_value":238.05,"total_display":"238.05","total_whole":"238","shares_owned_after":286328.0,"shares_owned_after_display":"286,328","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-20","filed_date":"2025-07-11","scope":"insider"}],"collapsed":true,"next_cursor":"2025-06-20|4536335","ledger_fault":false,"count":{"value":593,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":593,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":593},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001087294","name":"CUMBERLAND PHARMACEUTICALS INC","url":"/issuer/0001087294","role":"Director","n_filings":30,"first_seen":"2017-03-24","last_seen":"2025-09-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001695580","retrieved_at":"2026-08-22T09:16:36+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}